Attending LSX World Congress, London

Dr Karen Sullivan, CEO, is attending the LSX Congress 2024 in London and is pleased to be meeting with organisations interested in working with the company to achieve our commercial objectives.

May 2024

Galytx Awarded Innovate UK Funding

Galytx is pleased to announce that we have been awarded an Innovate UK Biomedical Catalyst Feasibility Award to support the achievement of commercial and technical milestones associated with our clinical development programme.

April 2024

.

.